Gilead Sciences, Inc. has announced that it has received new approval from the U.S. Food and Drug Administration (FDA) for a ...

Pharmaceutical stocks slumped after President Donald Trump sent letters to 17 drugmakers with an ultimatum to reduce drug ...

As we approach the 10th anniversary of the amendment to Federal Rule of Civil Procedure 26(b)(1), which called for “proportionality” of discovery requests and responses, it is appropriate to provide ...

An advocacy group is suing the Trump administration for failing to disclose details of a settlement with Gilead over patent ...

Dealmaking is in style again under President Donald Trump. Potential takeover targets include C3.ai, Viking Therapeutics, and ...

The letters demand US drug prices match or undercut global lows, triggering a 60-day compliance timeline, and prompting ...

Regions face reduced federal research funding and shrinking venture capital for startups, though rankings stay consistent.

Pheton Holdings Ltd (the “Company,” “we,” “our” or “Pheton”), a healthcare solution provider specializing in treatment ...

The Empowering Women in Fleet network will meet for its second regional meeting in September. Taking place on Friday, ...

Ligand to invest $35 million in exchange for a tiered royalty on future sales of Orchestra's AVIM therapy and Virtue SAB and an additional $5 million in an equity private placement • Medtronic to inve ...

Global Pulmonary Arterial Hypertension (PAH) Treatment Market is thriving due to a rising prevalence of pulmonary hypertension, advancements in drug development, increasing awareness about the disease ...

President Donald Trump sent letters to 17 pharmaceutical CEOs demanding lower drug prices within 60 days, following an ...